NEOBONA
LIVE

Serial Number

79193937

Owner

Synlab International GmbH

Filing Date

Jun 23, 2016

Add to watchlist:

No watchlists yet
View on USPTO

NEOBONA Trademark

Serial Number: 79193937 • Registration: 5273398

NEOBONA is a trademark filed by Synlab International GmbH on June 23, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Synlab International GmbH

Moosacher Str. 88

Entity Type: 99

SYNLAB LABCO

60 rue d'Hauteville

Entity Type: 33

Trademark Details

Filing Date

June 23, 2016

Registration Date

August 29, 2017

Published for Opposition

June 13, 2017

Cancellation Date

March 15, 2024

Goods & Services

Reagents for pregnancy tests for medical use; chemical preparations for the diagnosis of pregnancy; indicators for medical diagnosis, namely, diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; antiserums for diagnostic use, namely, diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use for medical purposes; diagnostic reagents and contrast media for medical use; preparations for ovulation tests, namely, chemical preparations for the diagnosis of pregnancy; diagnostic testing materials for medical use, namely, reagents and media for medical and veterinary diagnostic purposes; radio-isotope markers for therapeutic or diagnostic use; disinfectants for medical instruments; chromatography media for medical use, namely, preparations for detecting genetic predispositions for medical purposes; sanitary products for medical use, namely, sanitary preparations for medical use

Medical analysis services, namely, behavioural analysis for medical purposes; medical health-clinic services; blood analysis services; genetic testing for medical use; medical services for the diagnosis of medical conditions, namely, infertility; preparation of medical reports, namely, providing medical information to patients in the form of reports in the field of birth defects; provision of individual medical examination reports, namely, providing medical information to patients in the form of reports in the field of birth defects; human serum analysis services for medical treatments; medical services, namely in-vitro fertilization; medical treatment services in sanitary establishments, namely, in vitro fertilization; carrying out disease diagnoses, namely, medical diagnostic testing, monitoring and reporting services; surgical diagnostic services; paramedical services, namely, nursing care; medical treatment organization, namely, health care in the nature of health maintenance organizations; pharmaceutical consultancy services; health counseling services; medical assistance; in-vitro fertilization services; physiotherapy; hospital services; artificial insemination services; midwife services; chiropractics; telemedicine services; physical therapy services

Laboratory testing services, namely, genetic testing of laboratory animals for research purposes; computer-aided diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; chemical analysis and evaluation services; chemical analysis services for evaluation purposes; biological research services; scientific research; cosmetic research services; physics research services; chemical research services; technical research services in the field of pharmaceutical studies; research and development of new products for others; chemistry consultation services; scientific laboratory services; computer programming in the medical field; rental of laboratory apparatus and instruments; calibration services relating to medical equipment; quality control services

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Dec 21, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 4, 2024 INTS
INVALIDATION PROCESSED
Dec 4, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 16, 2024 INTR
CANCELLED SECTION 71
Mar 15, 2024 C71T
CHANGE OF OWNER RECEIVED FROM IB
Jan 5, 2024 CHLD
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 29, 2022 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 25, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 25, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 25, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 25, 2022 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 25, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 29, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 11, 2017 FICS
FINAL DISPOSITION PROCESSED
Dec 11, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 29, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 29, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 13, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jun 13, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 24, 2017 NONP
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 12, 2017 ADCH
APPROVED FOR PUB - PRINCIPAL REGISTER
May 2, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2017 TROA
REFUSAL PROCESSED BY IB
Nov 18, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 28, 2016 RFCS
REFUSAL PROCESSED BY MPU
Oct 27, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 25, 2016 RFCR
APPLICATION FILING RECEIPT MAILED
Oct 25, 2016 MAFR
NON-FINAL ACTION WRITTEN
Oct 24, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 21, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 20, 2016 REPR